G-CSF and Erythropoetin in Survival of Patients With Decompensated Liver Disease

NCT01384565 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Chronic Liver Disease

Interventions

DRUG: G-CSF+EPO
DRUG: Placebo

Sponsor

Institute of Liver and Biliary Sciences, India